Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After AlcoholSeptal Ablation.

Abstract

Atrioventricular block is a frequent major complication after alcohol septal ablation (ASA). The aim of this study was to evaluate the outcomes of patients with implanted permanent pacemaker (PPM) related to a high-grade atrioventricular block after ASA for hypertrophic obstructive cardiomyopathy. We used a multinational registry (the Euro-ASA registry) to evaluate the outcome of patients with PPM after ASA. A total of 1,814 patients were enrolled and followed up for 5.0 ± 4.3 years (median=4.0 years). A total of 170 (9.4%) patients underwent PPM implantation during the first 30days after ASA. Using propensity score matching, 139 pairs (n = 278) constituted the matched PPM and non-PPM groups. Between the matched groups, there were no long-term differences in New York Heart Association functional class (1.5 ± 0.7 vs 1.5 ± 0.9, P = 0.99) and survival (log-rank P = 0.47). Patients in the matched PPM group had lower long-term left ventricular (LV) outflow gradient (12±12 mm Hg vs 17 ± 19mmHg, P< 0.01), more pronounced LV outflow gradient decrease (81% ± 17% vs 72%±35%, P< 0.01), and lower LV ejection fraction (64% ± 8% vs 66% ± 8%, P = 0.02) and were less likely to undergo reintervention (re-ASA or myectomy) (log-rank P = 0.02). Patients with hypertrophic obstructive cardiomyopathy treated with ASA have a 9% probability of PPM implantation within 30days after ASA. In long-term follow-up, patients with PPM had similar long-term survival and New York Heart Association functional class but lower LV outflow gradient, a more pronounced LV outflow gradient decrease, a lower LV ejection fraction, and a lower likelihood of reintervention compared with patients without PPM.